About Cardea Pharmaceuticals Private Limited
Data last updated:
Cardea Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2014PTC270089.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pushpa Yadav and Vinod Kumar Yadav.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 28/142 Ground Floor West Patel Nagar, New Delhi, Delhi, India – 110008.
As per the financials filed for FY 2020, the company reported a revenue of ₹45,500, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3,449 (net margin -7.6%) and EBITDA of ₹11,050 (EBITDA margin 24.3%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years and 15% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cardea-pharma.com.
Company details
Contact details
Cardea Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is cardea-pharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address28/142 Ground Floor West Patel Nagar, New Delhi, Delhi, India – 110008
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cardea Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Cardea Pharmaceuticals Private Limited
FY 2021 filings availableCardea Pharmaceuticals Private Limited reported revenue of ₹45,500 (up 168% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 168% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 15%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹45,500 | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11,050 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3,449 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.3% | ||||
| Net Profit Margin | -7.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cardea Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cardea Pharmaceuticals Private Limited
Cardea Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pushpa Yadav | Director | 07 Aug 2014 | 12 Years 2 Months | Current |
| Vinod Kumar Yadav | Director | 07 Aug 2014 | 12 Years 2 Months | Current |
Auditor
Cardea Pharmaceuticals Private Limited is audited by OM PRAKASH YADAV & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| OM PRAKASH YADAV & CO | FY 2018 | 014923C |
Shareholding
The shareholding of Cardea Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Cardea Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cardea Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cardea Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cardea Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cardea Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Pushpa Yadav was appointed as Director on 07 Aug 2014.
Frequently asked questions
Cardea Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 August 2014 (12+ years old) and is registered under CIN U74900DL2014PTC270089.
Cardea Pharmaceuticals has 2 current directors:
- Pushpa Yadav - Director
- Vinod Kumar Yadav - Director
The latest financial statements of Cardea Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Cardea Pharmaceuticals is U74900DL2014PTC270089. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cardea Pharmaceuticals was incorporated on 07 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
Pushpa Yadav was appointed as Director on 07 Aug 2014. Vinod Kumar Yadav was appointed as Director on 07 Aug 2014.
Cardea Pharmaceuticals can be reached through the website cardea-pharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Cardea Pharmaceuticals is at 28142 Ground Floor West Patel Nagar, New Delhi, Delhi, India – 110008.
Cardea Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Cardea Pharmaceuticals is compliant as of 11 July 2026. The company is actively filing with the Registrar of Companies.